Effectiveness of iNTS vaccination in sub-Saharan Africa

Abstract Invasive non-Typhoidal Salmonella (iNTS) is one of the leading causes of blood stream infections in Sub-Saharan Africa, especially among children. iNTS can be difficult to diagnose, particularly in areas where malaria is endemic, and difficult to treat, partly because of the emergence of an...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniele Cassese, Nicola Dimitri, Gianluca Breghi, Tiziana Spadafina
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87659-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571711860506624
author Daniele Cassese
Nicola Dimitri
Gianluca Breghi
Tiziana Spadafina
author_facet Daniele Cassese
Nicola Dimitri
Gianluca Breghi
Tiziana Spadafina
author_sort Daniele Cassese
collection DOAJ
description Abstract Invasive non-Typhoidal Salmonella (iNTS) is one of the leading causes of blood stream infections in Sub-Saharan Africa, especially among children. iNTS can be difficult to diagnose, particularly in areas where malaria is endemic, and difficult to treat, partly because of the emergence of antibiotic resistance. We developed a mathematical model to evaluate the impact of a vaccine for iNTS in 49 countries of sub-Saharan Africa. Without vaccination we estimate 9.2 million new iNTS cases among children below 5 years old in these 49 countries from 2022 to 2038, 6.2 million of which between 2028 and 2038. The introduction of a $$85\%$$ ( $$95\%$$ ) efficacy vaccine in 2028 would prevent 2.6 (2.9) million of these new infections. We provide the country-specific impact of a iNTS vaccine considering the different age structures and vaccine coverage levels.
format Article
id doaj-art-2fbe3c8d27c746388c1e0ef4a71b0ab1
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2fbe3c8d27c746388c1e0ef4a71b0ab12025-02-02T12:20:59ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-025-87659-4Effectiveness of iNTS vaccination in sub-Saharan AfricaDaniele Cassese0Nicola Dimitri1Gianluca Breghi2Tiziana Spadafina3Department of Economics, University of CambridgeDepartment of Economics, Universitá degli Studi di SienaFondazione Achille Sclavo ONLUSFondazione Achille Sclavo ONLUSAbstract Invasive non-Typhoidal Salmonella (iNTS) is one of the leading causes of blood stream infections in Sub-Saharan Africa, especially among children. iNTS can be difficult to diagnose, particularly in areas where malaria is endemic, and difficult to treat, partly because of the emergence of antibiotic resistance. We developed a mathematical model to evaluate the impact of a vaccine for iNTS in 49 countries of sub-Saharan Africa. Without vaccination we estimate 9.2 million new iNTS cases among children below 5 years old in these 49 countries from 2022 to 2038, 6.2 million of which between 2028 and 2038. The introduction of a $$85\%$$ ( $$95\%$$ ) efficacy vaccine in 2028 would prevent 2.6 (2.9) million of these new infections. We provide the country-specific impact of a iNTS vaccine considering the different age structures and vaccine coverage levels.https://doi.org/10.1038/s41598-025-87659-4iNTSModelVaccinationEffectivenessSub-Saharan Africa
spellingShingle Daniele Cassese
Nicola Dimitri
Gianluca Breghi
Tiziana Spadafina
Effectiveness of iNTS vaccination in sub-Saharan Africa
Scientific Reports
iNTS
Model
Vaccination
Effectiveness
Sub-Saharan Africa
title Effectiveness of iNTS vaccination in sub-Saharan Africa
title_full Effectiveness of iNTS vaccination in sub-Saharan Africa
title_fullStr Effectiveness of iNTS vaccination in sub-Saharan Africa
title_full_unstemmed Effectiveness of iNTS vaccination in sub-Saharan Africa
title_short Effectiveness of iNTS vaccination in sub-Saharan Africa
title_sort effectiveness of ints vaccination in sub saharan africa
topic iNTS
Model
Vaccination
Effectiveness
Sub-Saharan Africa
url https://doi.org/10.1038/s41598-025-87659-4
work_keys_str_mv AT danielecassese effectivenessofintsvaccinationinsubsaharanafrica
AT nicoladimitri effectivenessofintsvaccinationinsubsaharanafrica
AT gianlucabreghi effectivenessofintsvaccinationinsubsaharanafrica
AT tizianaspadafina effectivenessofintsvaccinationinsubsaharanafrica